1 |
SCOTTONI F, DAVENPORT M. Biliary atresia: Potential for a new decade[J]. Semin Pediatr Surg, 2020,29(4):150940.
|
2 |
VIJ M, RELA M. Biliary atresia: pathology, etiology and pathogenesis [J]. Future Sci OA, 2020, 6(5):FSO466.
|
3 |
SIRISOMBOONLARP K, UDOMSINPRASERT W, MCCONACHIE E, et al. Increased serum glypican-3 is associated with liver stiffness and hepatic dysfunction in children with biliary atresia [J]. Clin Exp Hepatol, 2019, 5(1):48-54.
|
4 |
UDOMSINPRASERT W, ANGKATHUNYAKUL N, KLAIKEAW N, et al. Hepatic glypican-3 and alphα-smooth muscle actin overexpressions reflect severity of liver fibrosis and predict outcome after successful portoenterostomy in biliary atresia [J]. Surgery, 2020, 167(3):560-568.
|
5 |
罗声政,吴俊成,林仁坤,等.锌α2糖蛋白抑制肝星状细胞活化和增殖的体外研究[J].中华肝脏病杂志,2020,28(2):135-140.
|
6 |
公绪华,朱樑,陈超,等.miR-214通过激活肝星状细胞促进肝纤维化进程[J].上海交通大学学报(医学版),2020,40(6):776-784.
|
7 |
VARMA S, STEPHENNE X, KOMUTA M, et al. The histological quantification of alphα-smooth muscle actin predicts future graft fibrosis in pediatric liver transplant recipients [J]. Pediatr Transplant, 2017, 21(1).DOI:10.1111/petr.12834 .
doi: 10.1111/petr.12834
|
8 |
SHEN WJ, CHEN G, WANG M, et al. Liver fibrosis in biliary atresia [J]. World J Pediatr, 2019, 15(2):117-123.
|
9 |
于洪丽,喻文立,翁亦齐,等.亲体肝移植患儿围术期血清中脑损伤标志物水平的变化及临床意义[J].吉林大学学报(医学版),2021,47(1):168-172.
|
10 |
GUO M, ZHANG H, ZHENG J, et al. Glypican-3: A new target for diagnosis and treatment of hepatocellular carcinoma [J]. J Cancer, 2020, 11(8):2008-2021.
|
11 |
YIN L, ZHANG Y, SHI H, et al. Proteomic profiling of hepatic stellate cells in alcohol liver fibrosis reveals proteins involved in collagen production [J]. Alcohol, 2020, 86:81-91.
|
12 |
董美衬,李琦,刘向祎.Glypican-3与肝癌关系的研究现状与进展[J].中华检验医学杂志,2020,43(2):199-202.
|
13 |
ZHANG J, ZHANG M, MA H, et al. Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma: An updated metα-analysis [J]. Medicine (Baltimore), 2018, 97(24): e11130.
|
14 |
MONTALBANO M, RASTELLINI C, MCGUIRE J T,et al. Role of Glypican-3 in the growth, migration and invasion of primary hepatocytes isolated from patients with hepatocellular carcinoma [J]. Cell Oncol (Dordr), 2018, 41(2): 169-184.
|
15 |
FILMUS J, CAPURRO M. Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma[J]. FEBS J, 2013, 280(10):2471-2476.
|
16 |
SHIH TC, WANG L, WANG HC, et al. Glypican-3: A molecular marker for the detection and treatment of hepatocellular carcinoma [J]. Liver Res,2020, 4(4):168-172.
|
17 |
YEEH Y T, LIN N C, YEH Y C, et al. Vitamin A can ameliorate fibrosis of liver in an established rat model of biliary atresia and Kasai portoenterostomy [J]. J Pediatr Surg, 2018, 53(12):2416-2422.
|
18 |
徐加敏,唐映梅.胆管病变及其相关肝脏疾病的研究现状[J].临床肝胆病杂志,2019,35(4):934-936.
|
19 |
RAMACHANDRAN P, UNNY A K, VIJ M, et al. α-Smooth muscle actin expression predicts the outcome of Kasai portoenterostomy in biliary atresia [J]. Saudi J Gastroenterol, 2019, 25(2):101-105.
|
20 |
徐 莹,张定棋,陈佳美,等.肝脏微环境中各种细胞对肝星状细胞活化的影响[J].临床肝胆病杂志,2019,35(2):424-430.
|